252331-63-8 Usage
Description
1-(6-bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-Ethanone is a fluorinated organic compound that features a trifluoro-ethanone group and a 6-bromo-3,4-dihydro-2(1H)-isoquinolinyl group. This unique structure positions it as a promising candidate in medicinal chemistry and drug discovery research, particularly for the development of pharmaceuticals with potential antipsychotic or antidepressant properties.
Uses
Used in Pharmaceutical Development:
1-(6-bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-Ethanone is used as a key intermediate in the synthesis of new pharmaceuticals due to its distinctive chemical structure. The presence of bromine and isoquinolinyl groups allows for the creation of compounds that may exhibit antipsychotic or antidepressant effects, addressing significant unmet needs in mental health treatment.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(6-bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-Ethanone serves as a valuable building block for the design and synthesis of novel organic compounds. Its unique properties make it instrumental in exploring new therapeutic avenues and enhancing the pharmacological profiles of existing drugs.
Used in Drug Discovery:
1-(6-bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-Ethanone is utilized in drug discovery processes to identify and optimize lead compounds with potential therapeutic applications. Its structural attributes facilitate the development of innovative drugs that could improve patient outcomes and contribute to advancements in medical science.
Check Digit Verification of cas no
The CAS Registry Mumber 252331-63-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,3,3 and 1 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 252331-63:
(8*2)+(7*5)+(6*2)+(5*3)+(4*3)+(3*1)+(2*6)+(1*3)=108
108 % 10 = 8
So 252331-63-8 is a valid CAS Registry Number.
252331-63-8Relevant articles and documents
ARYL LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG
-
, (2015/06/03)
The present invention relates to aryl linked imidazole and triazole derivatives, compositions comprising said compounds, alone or in combination with other drugs, and methods of using the compounds for improving the pharmacokinetics of a drug. The compounds of the invention are useful in human and veterinary medicine for inhbiting CYP3A4 and for improving the pharmacokinetics of a therapeutic compound that is metabolized by CYP3A4.
HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF
-
Page/Page column 110-111, (2010/08/18)
Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.
ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF
-
Page/Page column 179, (2009/04/25)
This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
